A study published in the European Journal of Cardiovascular Nursing Nov. 28 found that nearly half of heart patients undergoing PCI admit to not understanding or remembering the bulk of the informed consent process, leaving them without a clear picture of the procedure and its potential benefits.

People with severe but stable ischemic heart disease don’t benefit any more from invasive CV procedures than they do from optimal medical therapy and lifestyle changes alone, according to results from the highly anticipated ISCHEMIA trial.

Research published in JAMA Nov. 12 suggests that, despite the Organ Procurement and Transplant Network’s overhaul of the U.S. heart allocation system in 2018, CV transplant programs still suffer from variability in survival benefit and a lack of standardized guidelines for ranking candidates.

Women face a greater risk of bleeding and hemorrhagic stroke after PCI than men, according to a new subgroup analysis of the GLOBAL LEADERS trial.

A 61-year-old patient at the West Virginia University Heart and Vascular Institute is the first in the state to receive a successful heart transplant, WVU reported Nov. 10.

Multiarterial CABG was linked to lower rates of long-term mortality, reintervention and MI than single-arterial CABG in a recent study of heart patients, suggesting the multiarterial approach is underused in contemporary practice.

Two studies reach conflicting conclusions while underscoring the need for best practice guidelines to fill the current vacuum.

Hackensack University Medical Center is the first practice in the U.S. to successfully perform heart surgeries using Abiomed’s Impella 5.5 LVAD.